In this episode, Nathan details his innovative project: a low-cost, modular headband for transcranial direct current stimulation. The goal is to build a platform for large-scale remote studies on brain activity, potentially aiding in treatments for depression and Alzheimer’s, and ultimately presenting this data to the FDA. Andrew provides an update on his podcast post-production … Continue reading Why 95% of Companies Fail at AI | EP 28 | 3reate